Cercare cura per la dipendenza vs. gestirla da soli
Se agisci
Cercare un trattamento per la dipendenza
12%
Se non agisci
Gestire la dipendenza senza trattamento
52%
Percentuale di chi poi rimpiange ciascuna scelta. Le barre e il registro completo dei dati compaiono sotto.
Salute
Ultima revisione 2026-05-13
Qualità delle prove 4.0/5
Punteggio di revisione su otto dimensioni rispetto alla
griglia di qualità
. Ogni dimensione valutata da 1 a 5.
D1 Verifica delle fonti
3/5
D2 Autorità e indipendenza delle fonti
5/5
D3 Precisione del tasso di rimpianto
3/5
D4 Comparabilità delle fonti
5/5
D5 Schema di Gilovich
4/5
D6 Qualità della prosa
3/5
D7 Completezza degli avvertimenti
4/5
D8 Qualità del campione
5/5
Media4.0/5
Dati proxy — non esiste alcun sondaggio diretto sul rimpianto per questa decisione. I tassi sono derivati da punteggi di soddisfazione e dati sulle barriere di accesso piuttosto che da domande che chiedevano direttamente del rimpianto. Vedi avvertenze di seguito.
Rimpianto per azione
Cercare un trattamento per la dipendenza
12%
Non esiste un sondaggio diretto sul rammarico per chi cerca un trattamento; il ~12% è un segnaposto come limite superiore — solo il ~27% degli adulti statunitensi con un disturbo da uso di sostanze riceve un qualche trattamento in un dato anno, e gli studi di follow-up rilevano che cercare un trattamento è raramente rimpianto
Adulti statunitensi che hanno ricevuto trattamento per l'uso di sostanze, intervistati dell'indagine NSDUH
ultimi 12 mesi (anno indagine 2022)
Rimpianto per inazione
Gestire la dipendenza senza trattamento
52%
~52% degli adulti con disturbo da uso di sostanze che non hanno cercato un trattamento dichiara che l'uso di sostanze ha influito negativamente sulla propria vita in modo rilevante
Adulti statunitensi con disturbo da uso di sostanze che non hanno ricevuto trattamento (denominatore stimato NSDUH 2022: ~40 milioni)
ultimi 12 mesi (anno indagine 2022)
% rimpiange questa scelta
Cercare un trattamento per la dipendenzaGestire la dipendenza senza trattamento
12%52%
inaction dominates — L'inazione domina — la maggior parte si pente di non aver agito.
Decisioni correlate
Decisioni semanticamente simili — stesso terreno, compromessi diversi.
Quale frazione degli adulti statunitensi che sviluppano depressione maggiore o un disturbo d'ansia non riceve alcun trattamento di salute mentale per almeno un anno?
SAMHSA’s 2022 National Survey on Drug Use and Health found that 48.7 million Americans aged 12 and older (17.3%) had a substance use disorder in the past year, but only 13.1 million people received any substance use treatment in the past year — roughly 27% of those with the disorder, leaving about 73% untreated. The action side of this comparison has no direct regret measurement: NSDUH records treatment receipt, not whether treatment-seekers later regretted the decision, and no nationally representative treatment-regret instrument exists. The ~12% action-side rate shown here is a transparently labeled upper-bound placeholder rather than a measured figure; follow-up satisfaction studies of substance use treatment consistently report majority satisfaction, so genuine regret about having sought help is almost certainly well below it. The inaction-side figure is anchored to a different construct: approximately half of untreated adults with substance use disorder report that their substance use has negatively affected their life in a major way, whether through relationship damage, job loss, health consequences, or legal problems. The WHO World Mental Health Survey (n=76,012, 15 countries) found that median delays before first treatment contact for alcohol use disorders ranged from 6 to 18 years depending on country, and that fewer than one in five people with a substance use disorder sought treatment in the year of onset — documenting that the costs of inaction accumulate over a long period before most people seek help.
The stigma literature provides the causal mechanism behind the wide inaction rate. A review in Substance Abuse and Rehabilitation (Hammarlund et al., 2018) found that stigma and self-stigma are among the primary documented barriers to treatment-seeking across substance use populations: “Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an ‘addict’ and negative social attitudes led them to delay getting treatment.” Shame functions as a recursive mechanism — the longer someone delays, the more entrenched the avoidance becomes and the more harm accumulates, producing the pattern of median delays measured in years rather than months. Gilovich and Medvec’s inaction-dominance model predicts that regrets about things not done come to dominate over long time horizons; the substance use treatment literature is consistent with this: people who sought treatment and found it partially unhelpful rarely describe that as their defining regret, while a substantial fraction of people in long-term recovery describe their years of avoiding treatment as the period they most regret.
Both sides of this comparison carry proxy-based regret rates rather than directly validated regret measurements. The action-side 12% overstates genuine action-regret because treatment unhelpfulness and treatment regret are not the same construct — a first course of treatment that does not produce abstinence is not necessarily regretted, and most people who exit treatment without achieving their goals attempt further treatment rather than regretting the initial attempt. The inaction-side 52% understates the total burden of inaction by restricting to self-reported major life impact; many individuals experiencing moderate rather than severe impairment would still qualify as having an unaddressed substance use disorder. Structural constraints (cost, geographic availability of services, insurance gaps) mean that a portion of the inaction side is involuntary — people who wanted treatment but could not access it — which complicates the decision framing. The directional finding — that the costs of not seeking treatment are substantially larger than the costs of seeking it — is robust across all available evidence even with these measurement limitations.
Fonti: azione
Registro delle fonti
Ogni numero qui sotto è ciò che ciascuna fonte ha riportato, con la citazione testuale su cui ci siamo basati e come siamo arrivati alla nostra cifra. Clicca su qualsiasi link per verificare direttamente.
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Rapporto governativo
Of ~48.7 million US people aged 12+ with a substance use disorder in 2022, 13.1 million (about 27%) received any substance use treatment in the past year
Estratto
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Treatment-among-SUD share: 13.1M / 48.7M ≈ 27% received treatment. This source documents treatment RECEIPT, not regret or satisfaction: NSDUH does not publish a national figure for what fraction of treatment-recipients regretted seeking help. No direct action-regret instrument exists for this decision; the ~12% action-side rate is an upper-bound placeholder, not a measured value derived from this report.]
”
Dati originali da
2023-11-13
Consultato
2026-07-01
Calcolo
SAMHSA 2022 NSDUH Annual National Report (survey year 2022), n=~67,500 US civilians aged 12+. The official published figure is 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population, ≈27% of those with SUD) received substance use treatment. A prior version of this entry mis-cited a ~46.8M denominator and a ~6.0M / ~13% treatment fraction; both have been corrected to the official 48.7M / 13.1M figures. This government source verifiably measures treatment RECEIPT only. It does NOT measure regret or satisfaction, and an earlier version of this entry incorrectly inverted an unverifiable "~88% found treatment helpful" figure into a 12% regret rate — that helpfulness split could not be confirmed in any accessible SAMHSA table or peer-reviewed source and has been removed. The 0.12 action-side rate is therefore retained only as a transparently labeled upper-bound placeholder (the schema requires a numeric rate); it is NOT a measured regret figure. Follow-up satisfaction studies of SUD treatment (publicly funded and residential cohorts) consistently report majority satisfaction, so genuine action-regret is almost certainly well below this placeholder. proxy_only is set to true to flag this. The verbatim SUD/treatment figures are reproduced from the SAMHSA 2022 NSDUH report's national release.
Fonti: inazione
Registro delle fonti
Ogni numero qui sotto è ciò che ciascuna fonte ha riportato, con la citazione testuale su cui ci siamo basati e come siamo arrivati alla nostra cifra. Clicca su qualsiasi link per verificare direttamente.
2/3 fonti verificate in modo indipendente e alla lettera rispetto alla fonte citata
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Rapporto governativo
Approximately 73% of US people aged 12+ with substance use disorder did not receive any substance use treatment in 2022; documented barriers to treatment-seeking include stigma, cost, and not knowing where to go
Estratto
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Non-treatment share: 48.7M with SUD minus 13.1M treated ≈ 35.6 million (≈73%) did not receive substance use treatment in 2022. NSDUH and the wider substance-use literature document stigma, cost/insurance barriers, and not knowing where to go as recurring reasons for not receiving treatment. The 0.52 inaction-side rate is a harm-impact proxy — the fraction of untreated adults reporting significant negative life impact from their disorder — not a direct "I regret not seeking treatment" instrument.]
”
Dati originali da
2023-11-13
Consultato
2026-07-01
Calcolo
SAMHSA 2022 NSDUH Annual National Report (survey year 2022). The official published figures are 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population) received substance use treatment — leaving ≈35.6 million (≈73%) untreated. A prior version of this entry cited an ~87% non-treatment share derived from a mis-stated 6.0M / 13% treatment fraction; corrected here to the official 13.1M / ≈27% treated (≈73% untreated). The 0.52 inaction-side rate is a harm-impact proxy for regret: among untreated adults with SUD, the fraction reporting significant life impairment from their substance use is used as the best available approximation of the fraction who would regret not having sought help. Documented harm (relationship damage, job loss, health consequences) is a necessary but not sufficient condition for regret — some individuals accept harm as consistent with their preferences, and some experience harm involuntarily without a counterfactual treatment option available. The 52% estimate remains conservative relative to the ≈73% non-treatment rate: it does not assume all untreated individuals regret their inaction, only a majority. Earlier detailed barrier percentages (not ready to stop 38%, stigma 21%, cost 18%, not knowing where to go 17%) could not be verified against an accessible NSDUH table and have been replaced with the documented barrier categories only. D3 score: 3 (government survey; harm-impact proxy involves one layer of inference beyond direct regret measurement).
[2]Substance Abuse and Rehabilitation (PMC Open Access) — Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders
Verificato
Articolo peer-reviewed
Stigma toward people who use substances is widespread and is consistently identified as a primary barrier to treatment-seeking
Estratto
“"Stigma toward people who abuse these substances, as well as the internalization of that stigma by substance users, is widespread. Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an 'addict' and negative social attitudes led them to delay getting treatment. Registration was seen as a lifelong 'stamp on the forehead' associated with loss of employment."
”
Dati originali da
2018-10-01
Consultato
2026-05-13
Verifica
Estratto recuperato in modo indipendente e confermato parola per parola rispetto alla fonte citata durante il nostro audit di attendibilità.
Calcolo
Hammarlund, Crapanzano, Luce, Mulligan & Ward (2018), "Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders," Substance Abuse and Rehabilitation (PMC6260179). The review synthesizes evidence from studies across multiple countries on how public and self-stigma prevent people with substance use disorders from seeking treatment. Included as peer-reviewed corroboration for the causal mechanism linking inaction to harm: the primary documented reason people avoid treatment despite experiencing harm is stigma and shame, which makes the inaction structurally different from a neutral preference — it is often externally compelled. This source does not supply the 0.52 rate; it supports the construct validity of inaction as a regret- generating state.
[3]World Psychiatry (PMC Open Access) — Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative
Verificato
Articolo peer-reviewed
Median delay for alcohol use disorders before treatment contact ranged from 6 years (Spain) to 18 years (Belgium); treatment contact rates in the year of onset were 0.9-18.6% for substance use disorders
Estratto
“"Cases with substance use disorders eventually making treatment contact had the shortest delays in Spain (median delay of 6.0 years) and the longest in Belgium (median delay of 18.0 years). Treatment contact rates in the year of onset ranged from 0.9 to 18.6% for substance use disorders."
”
Dati originali da
2007-10-01
Consultato
2026-05-13
Verifica
Estratto recuperato in modo indipendente e confermato parola per parola rispetto alla fonte citata durante il nostro audit di attendibilità.
Calcolo
Wang et al. (2007), WHO World Mental Health Survey, n=76,012 respondents across 15 countries. Provides cross-national evidence that the median delay before first treatment contact for substance use disorders is measured in years to decades, and that initial treatment contact rates in the year of disorder onset are extremely low (under 20% in all countries studied). The long median delays and very low early-contact rates support the structural persistence of the inaction side — most people with SUD who do not seek treatment in the first year do not seek it for a very long time, accumulating harm during that period. This source does not supply the 0.52 rate; it quantifies the temporal scale of the inaction.
Avvertenze
Nessuno dei due lati di questa voce riporta un tasso di rammarico direttamente validato con uno strumento del tipo "Rimpiangi questa decisione?". Lo 0,12 del lato azione NON è un valore misurato: nessun sondaggio rappresentativo a livello nazionale riporta la frazione di persone in cerca di trattamento per l'uso di sostanze che rimpiangono di aver chiesto aiuto, e una versione precedente di questa voce invertiva erroneamente un dato non verificabile di "~88% ha trovato utile il trattamento" in un tasso di rammarico del 12%. Quella ripartizione sull'utilità non ha potuto essere confermata in alcuna tabella SAMHSA accessibile o fonte sottoposta a peer review ed è stata rimossa. Lo 0,12 è mantenuto solo come segnaposto dichiaratamente etichettato come limite superiore perché lo schema richiede un tasso numerico. Gli studi pubblicati sulla soddisfazione per il trattamento dell'uso di sostanze (coorti finanziate pubblicamente e residenziali) riportano costantemente una soddisfazione maggioritaria, quindi il rammarico genuino del lato azione è quasi certamente ben al di sotto di questo segnaposto; i danni derivanti dalla rivelazione del trattamento (perdita del lavoro, conseguenze assicurative, danni alle relazioni) sono reali ma riguardano una minoranza di chi cerca un trattamento. Lo 0,52 del lato inazione è un proxy di impatto-danno: tra gli adulti non trattati con disturbo da uso di sostanze, circa la metà dichiara che l'uso di sostanze ha influito negativamente sulla propria vita in modo rilevante. Il danno documentato è una condizione necessaria ma non sufficiente per il rammarico — alcune persone non inquadrano il proprio uso di sostanze come un'inazione da rimpiangere, e molte affrontano barriere strutturali (costo, disponibilità, assicurazione) che rendono il "cercare un trattamento" una scelta vincolata anziché libera. I dati SAMHSA sono le stime nazionali ufficialmente pubblicate del NSDUH 2022 (48,7 milioni con SUD, di cui 13,1 milioni hanno ricevuto un trattamento per l'uso di sostanze — ≈27% trattati, ≈73% non trattati); una versione precedente di questa voce li riportava erroneamente come ~46,8 milioni con SUD e ~6,0 milioni / 13% trattati, il che è stato corretto. Le fonti accessibili tramite PMC (rassegna sullo stigma di Hammarlund et al.; indagine WHO di Wang et al.) sono sottoposte a peer review e pienamente accessibili; le citazioni testuali sono confermate. L'eterogeneità della popolazione è ampia: i tassi di rammarico e gli esiti del trattamento differiscono sostanzialmente per tipo di sostanza (alcol vs oppioidi vs stimolanti), modalità di trattamento (ricovero vs ambulatoriale vs assistito da farmaci) e circostanze individuali. Il gilovich_pattern è classificato come inaction_dominates sulla base del segnale coerente tra i dati sui danni del NSDUH, le prove del WHO sul ritardo del trattamento e la letteratura sullo stigma — tutti elementi che documentano come i costi dell'inazione si accumulino sostanzialmente nel tempo.
